Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Human autoantibodies specific for PAD3 which are cross-reactive with PAD4 and their use in the diagnosis and treatment of rheumatoid arthritis and related diseases

Human autoantibodies specific for PAD3 which are cross-reactive with PAD4 and their use in the diagnosis and treatment of rheumatoid arthritis and related diseases

US Patent 8975033 · Granted Mar 10, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-PAD2 antibody for treating and evaluating autoimmune and inflammatory disea2025
Anti-PAD2 antibody for treating and evaluating autoimmune and inflammatory disea2025
Autoimmune antibodies for use in inhibiting cancer cell growth2024
Materials and methods for assessing cancer risk and treating cancer2022
Methods for identifying patterns of IFN induced expression and use in diagnosis,2022
Autoimmune antigens and cancer2020
Autoimmune antigens and cancer2020
Compositions and methods for characterizing a myopathy2016
Human autoantibodies specific for PAD3 which are cross-reactive with PAD4 and th2016
Human autoantibodies specific for PAD3 which are cross-reactive with PAD4 and th2016
Human autoantibodies specific for PAD3 which are cross-reactive with PAD4 and th2016
Human autoantibodies specific for PAD3 which are cross-reactive with PAD4 and th2016